Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Mackensen

Showing results (11-20 of 231) with videos related to

Pageof 24
Sort By:
Onkologie|August 8, 2013
[Targeted therapy: old and new possibilities]Andreas Hochhaus, Diana Lüftner, Andreas Mackensen
Lancet (London, England)|July 27, 2024
CAR T-cell perspectives in lupus - Authors' replyGeorg Schett, Andreas Mackensen, Dimitrios Mougiakakos
Cancer Immunology, Immunotherapy : CII|December 16, 2004
Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapyChristian Blank, Thomas F Gajewski, Andreas Mackensen
Oncotarget|February 5, 2019
Combination of lenalidomide and vitamin D enhances MOR202-mediated cytotoxicity of macrophages: It takes three to tangoCindy Flamann, Leonhard Busch, Andreas Mackensen, et al.
Cancer Immunology, Immunotherapy : CII|January 18, 2011
Suppression of T-cell responses by tumor metabolitesKatrin Singer, Eva Gottfried, Marina Kreutz, et al.
Onkologie|April 21, 2012
[Foreword]Axel Hauschild, Oliver Kölbl, Andreas Mackensen, et al.
Innere Medizin (Heidelberg, Germany)|June 30, 2025
[CAR T cells in non-malignant diseases]Fabian Müller, Melanie Hagen, Georg Schett, et al.
Onkologie|March 31, 2011
[Forward]Axel Hauschild, Oliver Kölbl, Andreas Mackensen, et al.
Oncology Research and Treatment|May 14, 2015
[Preface]Alexander Hauschild, Oliver Kölbl, Andreas Mackensen, et al.
Onkologie|June 26, 2013
[Foreword]Axel Hauschild, Oliver Kölbl, Andreas Mackensen, et al.
Pageof 24

Showing results (11-20 of 231) with videos related to

Sort By:
Pageof 24
Onkologie|August 8, 2013
[Targeted therapy: old and new possibilities]Andreas Hochhaus, Diana Lüftner, Andreas Mackensen
Lancet (London, England)|July 27, 2024
CAR T-cell perspectives in lupus - Authors' replyGeorg Schett, Andreas Mackensen, Dimitrios Mougiakakos
Cancer Immunology, Immunotherapy : CII|December 16, 2004
Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapyChristian Blank, Thomas F Gajewski, Andreas Mackensen
Oncotarget|February 5, 2019
Combination of lenalidomide and vitamin D enhances MOR202-mediated cytotoxicity of macrophages: It takes three to tangoCindy Flamann, Leonhard Busch, Andreas Mackensen, et al.
Cancer Immunology, Immunotherapy : CII|January 18, 2011
Suppression of T-cell responses by tumor metabolitesKatrin Singer, Eva Gottfried, Marina Kreutz, et al.
Onkologie|April 21, 2012
[Foreword]Axel Hauschild, Oliver Kölbl, Andreas Mackensen, et al.
Innere Medizin (Heidelberg, Germany)|June 30, 2025
[CAR T cells in non-malignant diseases]Fabian Müller, Melanie Hagen, Georg Schett, et al.
Onkologie|March 31, 2011
[Forward]Axel Hauschild, Oliver Kölbl, Andreas Mackensen, et al.
Oncology Research and Treatment|May 14, 2015
[Preface]Alexander Hauschild, Oliver Kölbl, Andreas Mackensen, et al.
Onkologie|June 26, 2013
[Foreword]Axel Hauschild, Oliver Kölbl, Andreas Mackensen, et al.
Pageof 24